BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szczukowski Ł, Krzyżak E, Zborowska A, Zając P, Potyrak K, Peregrym K, Wiatrak B, Marciniak A, Świątek P. Design, Synthesis and Comprehensive Investigations of Pyrrolo[3,4-d]pyridazinone-Based 1,3,4-Oxadiazole as New Class of Selective COX-2 Inhibitors. Int J Mol Sci 2020;21:E9623. [PMID: 33348757 DOI: 10.3390/ijms21249623] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Hassan MSA, Ahmed EM, El-Malah AA, Kassab AE. Anti-inflammatory activity of pyridazinones: A review. Arch Pharm (Weinheim) 2022;:e2200067. [PMID: 35532263 DOI: 10.1002/ardp.202200067] [Reference Citation Analysis]
2 Ruslin R, Yamin Y, Kasmawati H, Mangrura S, Kadidae L, Armid A, Arba M. The Search for Cyclooxygenase-2 (COX-2) Inhibitors for the Treatment of Inflammation Disease: An in-silico Study. JMDH 2022;Volume 15:783-91. [DOI: 10.2147/jmdh.s359429] [Reference Citation Analysis]
3 Palumbo Piccionello A. Editorial for Special Issue "Bioactive Oxadiazoles". Int J Mol Sci 2021;22:3988. [PMID: 33924410 DOI: 10.3390/ijms22083988] [Reference Citation Analysis]
4 Jeelan Basha N, Basavarajaiah SM, Shyamsunder K. Therapeutic potential of pyrrole and pyrrolidine analogs: an update. Mol Divers. [DOI: 10.1007/s11030-022-10387-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Szczukowski Ł, Krzyżak E, Wiatrak B, Jawień P, Marciniak A, Kotynia A, Świątek P. New N-Substituted-1,2,4-triazole Derivatives of Pyrrolo[3,4-d]pyridazinone with Significant Anti-Inflammatory Activity-Design, Synthesis and Complementary In Vitro, Computational and Spectroscopic Studies. Int J Mol Sci 2021;22:11235. [PMID: 34681894 DOI: 10.3390/ijms222011235] [Reference Citation Analysis]
6 Ju Z, Li M, Xu J, Howell DC, Li Z, Chen F. Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years. Acta Pharmaceutica Sinica B 2022;12:2790-807. [DOI: 10.1016/j.apsb.2022.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ahmadi M, Bekeschus S, Weltmann K, von Woedtke T, Wende K. Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors. RSC Med Chem . [DOI: 10.1039/d1md00280e] [Reference Citation Analysis]
8 Szkatuła D, Krzyżak E, Stanowska P, Duda M, Wiatrak B. A New N-Substituted 1H-Isoindole-1,3(2H)-Dione Derivative-Synthesis, Structure and Affinity for Cyclooxygenase Based on In Vitro Studies and Molecular Docking. Int J Mol Sci 2021;22:7678. [PMID: 34299298 DOI: 10.3390/ijms22147678] [Reference Citation Analysis]
9 Yang Z, Fang Y, Kim JM, Lee KT, Park H. Synthesis of Halogenated 1,5-Diarylimidazoles and Their Inhibitory Effects on LPS-Induced PGE2 Production in RAW 264.7 Cells. Molecules 2021;26:6093. [PMID: 34684673 DOI: 10.3390/molecules26206093] [Reference Citation Analysis]
10 Sharma D, Om H, Sharma AK. Potential Synthetic Routes and Metal-Ion Sensing Applications of 1,3,4-Oxadiazoles: An Integrative Review. Crit Rev Anal Chem 2022;:1-21. [PMID: 35617470 DOI: 10.1080/10408347.2022.2080494] [Reference Citation Analysis]
11 Peregrym K, Szczukowski Ł, Wiatrak B, Potyrak K, Czyżnikowska Ż, Świątek P. In Vitro and In Silico Evaluation of New 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]pyridazinone as Promising Cyclooxygenase Inhibitors. Int J Mol Sci 2021;22:9130. [PMID: 34502040 DOI: 10.3390/ijms22179130] [Reference Citation Analysis]
12 Qiao Y, Qin Y, Liu L, Chen X, Li Y, Li Q. An Investigation into the Interaction between Double Hydroxide-Based Antioxidant Benzophenone Derivatives and Cyclooxygenase 2. Molecules 2021;26:6622. [PMID: 34771031 DOI: 10.3390/molecules26216622] [Reference Citation Analysis]